English  |  正體中文  |  简体中文  |  2817768  
???header.visitor??? :  27932684    ???header.onlineuser??? :  69
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"lin h w"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 126-150 of 342  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-02-14T02:50:05Z Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism WEN-FANG CHENG; Chang M.-C.; Sun W.-Z.; Lee C.-N.; Lin H.-W.; Su Y.-N.; Hsieh C.-Y.; Chen C.-A.
臺大學術典藏 2020-02-14T02:49:55Z Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:53Z Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses Chen Y.-L.; Chang M.-C.; WEN-FANG CHENG; Lin H.-W.; Chen C.-A.; Chien C.-L.
臺大學術典藏 2020-02-14T02:49:52Z Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma Chen Y.-L.; WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.
臺大學術典藏 2020-02-14T02:49:48Z Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma Chiang Y.-C.;Lin H.-W.;Chang C.-F.;Chang M.-C.;Fu C.-F.;Chen T.-C.;Hsieh S.-F.;Chen C.-A.;Wen-Fang Cheng; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:47Z IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients Chen Y.-L.;Chou C.-Y.;Chang M.-C.;Lin H.-W.;Huang C.-T.;Hsieh S.-F.;Chen C.-A.;Wen-Fang Cheng; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:40Z Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment Chang M.-C.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Hsieh S.-F.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chang M.-C.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Hsieh S.-F.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:39Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation Chen Y.-L.;Chang M.-C.;Chiang Y.-C.;Lin H.-W.;Sun N.-Y.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:36Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells Lin H.-W.;Chiang Y.-C.;Sun N.-Y.;Chen Y.-L.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Wen-Fang Cheng; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:34Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes Sun N.-Y.;Chen Y.-L.;Lin H.-W.;Chiang Y.-C.;Chang C.-F.;Tai Y.-J.;Chen C.-A.;Sun W.-Z.;Chien C.-L.;Wen-Fang Cheng; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG
臺大學術典藏 2020-02-14T02:49:33Z mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Chen Y.-L.;Lin H.-W.;Sun N.-Y.;Yie J.-C.;Hung H.-C.;Chen C.-A.;Sun W.-Z.;Wen-Fang Cheng; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.
臺大學術典藏 2020-02-14T02:49:32Z BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Lai Y.-L.; Lin H.-W.; Chien C.-L.; Chen Y.-L.; Chen Y.-L.;Lin H.-W.;Chien C.-L.;Lai Y.-L.;Sun W.-Z.;Chen C.-A.;Wen-Fang Cheng
臺大學術典藏 2020-02-12T04:06:07Z Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism Chen C.-A.;Hsieh C.-Y;Su Y.-N;Lin H.-W;CHIEN-NAN LEE;Sun W.-Z;Chang M.-C;Cheng W.-F; Cheng W.-F; Chang M.-C; Sun W.-Z; CHIEN-NAN LEE; Lin H.-W; Su Y.-N; Hsieh C.-Y; Chen C.-A.
臺大學術典藏 2020-02-06T05:22:20Z Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism Sun W.-Z.; Lee C.-N.; Lin H.-W.; Su Y.-N.; Hsieh C.-Y.; Chen C.-A.; WEN-FANG CHENG; Chang M.-C.; Sun W.-Z.; Lee C.-N.; Lin H.-W.; Su Y.-N.; Hsieh C.-Y.; Chen C.-A.; Chang M.-C.; WEN-FANG CHENG; Chen C.-A.;Hsieh C.-Y.;Su Y.-N.;Lin H.-W.;Lee C.-N.;Sun W.-Z.;Chang M.-C.;WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:22:18Z Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways Sun W.-Z.;Hsieh C.-Y.;Lin H.-W.;Chen C.-A.;WEN-FANG CHENG;Chang M.-C.;Hsiao P.-N.; Hsiao P.-N.; Chang M.-C.; WEN-FANG CHENG; Chen C.-A.; Lin H.-W.; Hsieh C.-Y.; Sun W.-Z.; Hsiao P.-N.; Chang M.-C.; WEN-FANG CHENG; Chen C.-A.; Lin H.-W.; Hsieh C.-Y.; Sun W.-Z.
臺大學術典藏 2020-02-06T05:22:07Z Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways WEN-FANG CHENG;Lin Chiang W.-H.;Lin H.-W.;Mao T.-L.;Chen Y.-L.;Chiang Y.-C.;Chen P.-J.;Chen C.-A.;Chang M.-C.; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG; Chang M.-C.; Chen C.-A.; Chen P.-J.; Chiang Y.-C.; Chen Y.-L.; Mao T.-L.; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:22:07Z Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response WEN-FANG CHENG;Hsieh C.-Y.;Chen C.-A.;Lin H.-W.;Chiang Y.-C.;Huang C.-Y.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Huang C.-Y.; Chiang Y.-C.; Lin H.-W.; Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Huang C.-Y.; Chiang Y.-C.; Lin H.-W.; Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:22:05Z Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses Chien C.-L.;WEN-FANG CHENG;Lin H.-W.;Chen C.-A.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chen C.-A.; Lin H.-W.; WEN-FANG CHENG; Chien C.-L.; Chien C.-L.; Chen Y.-L.; Chang M.-C.; Chen C.-A.; Lin H.-W.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:22:04Z Interferon-gamma in ascites could be a predictive biomarker of outcome in ovarian carcinoma WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen C.-A.;Chien C.-L.;Huang C.-T.;Lin H.-W.;Chang M.-C.;WEN-FANG CHENG;Chen Y.-L.; Chen Y.-L.; WEN-FANG CHENG; Chang M.-C.; Lin H.-W.; Huang C.-T.; Chien C.-L.; Chen C.-A.; Chen Y.-L.
臺大學術典藏 2020-02-06T05:21:59Z Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Chen T.-C.;Fu C.-F.;Chang M.-C.;Chang C.-F.;Lin H.-W.;Chiang Y.-C.; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:58Z IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Huang C.-T.;Lin H.-W.;Chang M.-C.;Chou C.-Y.;Chen Y.-L.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:50Z Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:48Z CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Lin H.-P.;Lu T.-P.;Chang M.-C.;Fu C.-F.;Lin H.-W.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:48Z CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG
臺大學術典藏 2020-02-06T05:21:45Z Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG

Showing items 126-150 of 342  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page